— Know what they know.
Not Investment Advice

LBRX NASDAQ

LB Pharmaceuticals Inc Common Stock
1W: -3.3% 1M: +4.6% 3M: +1.6% YTD: +93.9% 1Y: +148.2%
$39.64
+0.30 (+0.76%)
Pre-Market: $43.82 (+4.18, +10.54%)
Weekly Expected Move ±8.8%
$32 $35 $39 $42 $46
NASDAQ · Healthcare · Biotechnology · Tech Score Buy · Power 62 · $1.3B mcap · 24M float · 1.56% daily turnover · Short 72% of daily vol
Credit Risk of going bust: lower than 80% of companies Debt: 0.4% of company value Bonds: none of note held by US funds details ▾
Of US companies ranked in the safest four tenths, about 1 in 3,500 filed for bankruptcy within a year (2020-2025).
If the stock fell to about $0.02 (down 99.9%), LB Pharmaceuticals Inc Common Stock would be worth roughly what it owes.
Total debt $5.2M against a stock market value of $1.28B.
Distance to default 9.71 (Merton model): prices to 2026-10-27, balance sheet 2026-06-30, debt counted $2.6M (short-term plus half of long-term), stock volatility 62.4%; Altman Z'' 14.47. A ranking and a back-test, not a forecast.
US fund filings (SEC N-PORT) show under $25M of this company's bonds, so there is no bond page. Its debt may be bank loans or privately placed. How these are computed.
Oct Typical
☁️
Cloudy
+0.0% YTD avg
2026 Now
☁️
Cloudy
Tracking typical
20yr Avg YTD
—
2026 YTD
—
Typical Vol
58%
Annualized
Monthly Weather Forecast
Jan
20yr
⛈️
-3.6%
0% win 87% vol
Feb
20yr
💨
+11.9%
100% win 64% vol
Mar
20yr
💨
+2.7%
100% win 48% vol
Apr
20yr
💨
+28.6%
100% win 68% vol
May
20yr
⛈️
-11.8%
0% win 45% vol
Jun
20yr
💨
+16.1%
100% win 44% vol
Jul
20yr
💨
+23.5%
100% win 67% vol
Aug
20yr
💨
+17.9%
100% win 57% vol
Sep
20yr
⛈️
-13.8%
0% win 49% vol
Oct
20yr
💨
+2.7%
100% win 58% vol
Now: +3.3%
Nov
20yr
💨
+10.3%
100% win 85% vol
Dec
20yr
💨
+25.1%
100% win 77% vol

Sign in to InsiderStreet

You'll also get our free weekly newsletter with
smart money signals, market insights, and alpha ideas.
Unsubscribe anytime.

For informational purposes only. Not investment advice. Data sourced from SEC filings. Privacy Terms